The DOI matches its Crossref record.
Marijuana withdrawal among adults seeking treatment for marijuana dependence.
Abstract
AIMS: The clinical relevance of marijuana withdrawal has not been established. This study is the first to document the incidence and severity of perceived marijuana withdrawal symptoms in a clinical sample of marijuana-dependent adults. MEASUREMENTS: Fifty-four people seeking outpatient treatment for marijuana dependence completed a 22-item Marijuana Withdrawal Symptom checklist based on their most recent period of marijuana abstinence. FINDINGS: The majority (57%) indicated that they had experienced > or = six symptoms of at least moderate severity and 47% experienced > or = four symptoms rated as severe. Withdrawal severity was greater in those with psychiatric symptomatology and more frequent marijuana use. CONCLUSIONS: This study provides further support for a cluster of withdrawal symptoms experienced following cessation of regular marijuana use. The affective and behavioral symptoms reported were consistent with those observed in previous laboratory and interview studies. Since withdrawal symptoms are frequently a target for clinical intervention with other substances of abuse, this may also be appropriate for marijuana.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“six-session CBT produced superior results when compared with a single CBT session in another clinical trial 25.”
From Psychosocial and pharmacological interventions for the treatment of cannabis use disorder (2018) · cites this paper as [25]
Citations
Cited by
Sorted by citations
Items 201–300 of 350
Rabin, R. A., Kozak, K., Zakzanis, K. K., et al. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.05.006 · Cited by 15
Self-citationAssessing Cannabis Use in People with Psychosis
Chesney, E., Lawn, W., & McGuire, P. K. (2023) · Cannabis and Cannabinoid Research · doi:10.1089/can.2023.0032 · Cited by 14
Cannabinoid hyperemesis syndrome: prevalence and management in an era of cannabis legalization
Stubbs, J. J., & McCallum, R. W. (2023) · Journal of Investigative Medicine · doi:10.1177/10815589231217495 · Cited by 14
Khani, F., Pourmotabbed, A., Hosseinmardi, N., Nedaei, S. E., Fathollahi, Y., & Azizi, H. (2022) · Developmental Psychobiology · doi:10.1002/dev.22315 · Cited by 13
Lee, D., Vandrey, R. G., Mendu, D. R., Anizan, S., Milman, G., Murray, J. A., Barnes, A. J., & Huestis, M. A. (2013) · Clinical Chemistry · doi:10.1373/clinchem.2013.207316 · Cited by 14
Cannabis and psychopathology : update 2004.
Grover, S., & Basu, D. (2004) · PubMed Central · Cited by 14
Wightman, R., Metrik, J., Lin, T. R., Li, Y., Badea, A., Almeida, R., Collins, A. B., & Beaudoin, F. L. (2023) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2023.03.005 · Cited by 13
Kroon, E., Cousijn, J., Filbey, F. M., Berchtold, C., Binz, T. M., & Kuhns, L. (2024) · Psychopharmacology · doi:10.1007/s00213-024-06558-0 · Cited by 12
“; Budney et al. 1999), Marijuana Craving Questionnaire (MCQ; Heishman et al. 2009), and a craving Visual Analogue Scale (VAS; Mot-tola 1993).”
Feasibility and effects of galantamine on cognition in humans with cannabis use disorder
Sugarman, D. E., Aquino, J. P. D., Poling, J. C., & Sofuoglu, M. (2019) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2019.05.004 · Cited by 13
Parrott, A. (2018) · Brain Sciences · doi:10.3390/brainsci8030043 · Cited by 17
“These symptoms of cannabis withdrawal have been formalized in standardized questionnaires such as the Cannabis Withdrawal Discomfort Scale [47], and the Marijuana Craving Questionnaire [48].”
MethodFilbey, F. M., Beaton, D., & Prashad, S. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110183 · Cited by 13
Effects of 28 days of cannabis abstinence on cognition in major depressive disorder: A pilot study
Sorkhou, M., Rabin, R. A., Rabin, J. S., Kloiber, S. M., McIntyre, R. S., & George, T. P. (2022) · American Journal on Addictions · doi:10.1111/ajad.13305 · Cited by 13
Tolerance and dependence to Δ9-tetrahydrocannabinol in rhesus monkeys: Activity assessments
Wilkerson, J. L., Schulze, D. R., & McMahon, L. R. (2019) · PLoS ONE · doi:10.1371/journal.pone.0209947 · Cited by 12
Ek, J., Jacobs, W. S., Kaylor, B. D., & McCall, W. V. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-61663-2_12 · Cited by 14
A Review of the Effects of Adolescent Cannabis Use on Physical Health
Tuvel, A. L., Winiger, E. A., & Ross, J. M. (2022) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2022.07.005 · Cited by 16
Prashad, S., Hammonds, R., Wiese, A. L., Milligan, A. L., & Filbey, F. M. (2020) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2020.107931 · Cited by 11
Craving is associated with amygdala volumes in adolescent marijuana users during abstinence
Padula, C. B., McQueeny, T. M., Lisdahl, K. M., Price, J. S., & Tapert, S. F. (2015) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952990.2014.966198 · Cited by 11
“The Cannabis Withdrawal Symptom Checklist (41) assessed MJ-related craving and withdrawal symptoms, including mood, somatic complaints, and sleep problems, on a 10-point Likert scale (0¼ no intensity; 10¼most intense).”
MethodClaus, B. B., Specka, M., McAnally, H. B., Scherbaum, N., Schifano, F., & Bonnet, U. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.598150 · Cited by 11
Wightman, R., Metrik, J., Lin, T. R., Collins, A. B., & Beaudoin, F. L. (2023) · Academic Emergency Medicine · doi:10.1111/acem.14773 · Cited by 10
Parrott, A. C., Hayley, A. C., & Downey, L. A. (2017) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2594 · Cited by 10
Psychosis associated with cannabis withdrawal: systematic review and case series
Chesney, E., Reilly, T. J., Scott, F., Slimani, I., Sarma, A., Kornblum, D., Oliver, D., & McGuire, P. K. (2024) · The British Journal of Psychiatry · doi:10.1192/bjp.2024.175 · Cited by 9
“65 Interestingly, even though women experience more withdrawal symptoms overall, 66 particularly gastrointestinal and mood symptoms, men are more likely than women to report insomnia and vivid dreams during periods of cannabis withdrawal.”
Gräfe, E. L., Reid, H. M. O., Shkolnikov, I., Conway, K., Kit, A., Acosta, C., & Christie, B. R. (2023) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2023.101076 · Cited by 10
Abus et dépendance au cannabis à l'adolescence
Phan, O., Corcos, M., Girardon, N., Nezelof, S., & Jeammet, P. (2005) · Encyclopédie médico-chirurgicale. Psychiatrie · doi:10.1016/j.emcps.2005.07.001 · Cited by 10
Michael Kiang, A., Christensen, B. K., Streiner, D. L., Roy, C., Patriciu, I., & Zipursky, R. B. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2800-3 · Cited by 9
“Participants identified as daily cannabis users on the TLFB, and who last used cannabis more than 5 h previously, were administered a modified, interviewer-rated version of the Cannabis Withdrawal Checklist (Budney et al. 1999) to rule out the presence of cannabis withdrawal syndrome.”
MethodMarijuana Craving Questionnaire (MCQ-SF/Versão Brasil): validação semântica
Pedroso, R. S., de Castro, M. D. G. T., & Araújo, R. B. (2009) · Jornal Brasileiro de Psiquiatria · doi:10.1590/s0047-20852009000400001 · Cited by 9
Los productos de Cannabis sativa: situación actual y perspectivas en medicina
Carranza, R. R. (2012) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 9
The association between physical pain and cannabis use in daily life: An experience sampling method
Sznitman, S. R., Baruch, Y. B., Greene, T., & Gelkopf, M. (2018) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2018.07.014 · Cited by 9
Impey, D., El-Marj, N., Parks, A., Choueiry, J., Fisher, D. J., & Knott, V. (2015) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2015.07.002 · Cited by 9
Psychotherapeutic interventions for cannabis abuse and/or dependence in outpatient settings
Denis, C., Lavie, E., Fatseas, M., & Auriacombe, M. (2005) · doi:10.1002/14651858.cd005336 · Cited by 9
RetractedChauchard, É., Goutaudier, N., Heishman, S. J., Gorelick, D. A., & Chabrol, H. (2014) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952990.2014.984069 · Cited by 8
“In one outpatient study, 93% of 54 adults seeking treatment for moderate-severe cannabis use disorder reported experiencing moderate craving, and 44% reported intense craving (11).”
BackgroundRogerson, B., Copeland, J., Buttner, P. G., et al. (2013) · BMJ Open · doi:10.1136/bmjopen-2013-002951 · Cited by 8
“Of particular clinical importance, withdrawal contributes to difficulties abstaining from cannabis(5) and increases the likelihood of relapse in order to relieve withdrawal distress.(6) 7 The proposed DSM-5 cannabis withdrawal syndrome criteria are informed by studies conducted mainly in treatmentseeking groups and ad…”
BackgroundMorel, A., Lebard, P., Dereux, A., Azuar, J., Questel, F., Bellivier, F., Cynthia Marie-claire, A., Fatseas, M., Vorspan, F., & Bloch, V. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.565617 · Cited by 9
“The primary outcome was assessed by 2 withdrawal scales: the CWS (38) and the Marijuana Withdrawal Scale (MWC) (41).”
MethodNabilone therapy for cannabis withdrawal presenting as protracted nausea and vomiting
Lam, P. W., & Frost, D. (2014) · BMJ Case Reports · doi:10.1136/bcr-2014-205287 · Cited by 8
Marijuana: An Overview of the Empirical Literature
Zvolensky, M. J., Bonn‐Miller, M. O., Leyro, T. M., Johnson, K. A., & Bernstein, A. (2010) · Springer eBooks · doi:10.1007/978-1-4419-0338-9_20 · Cited by 8
“, relative early in the marijuana using career [14, 29, 103, 101]) and may have clinical importance in terms of predicting relapse [19], although current data are not yet developed enough to yield conclusions in this regard.”
BackgroundA Review of Marijuana Assessment Dilemmas: Time for Marijuana Specific Screening Methods?
Alexander, D. (2003) · Journal of Social Work Practice in the Addictions · doi:10.1300/j160v03n04_02 · Cited by 8
Cannabis Withdrawal and Psychiatric Intensive Care
Malik, A., Shetty, H., Oliver, D., et al. (2025) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2025.1216 · Cited by 7
Brown, T., Ackerman, R. A., Kroon, E., Kuhns, L., Cousijn, J., & Filbey, F. M. (2024) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2024.2362832 · Cited by 7
“A single item from the Marijuana Withdrawal Checklist (MWC (38)) was used to assess sleep.”
Cannabis Withdrawal Among Detained Adolescents: Exploring the Impact of Nicotine and Race
Bassett, S. S., Stein, L. A. R., Brown, J. D., Stengel, J. R., Rossi, J. S., & Lebeau, R. (2015) · Journal of Child & Adolescent Substance Abuse · doi:10.1080/1067828x.2013.770379 · Cited by 8
“2 Measures As part of the assessment battery, adolescents completed a demographic questionnaire containing questions about socio-demographic factors and frequency of substance use prior to detention, and the Marijuana Withdrawal Checklist (MWC; Budney et al., 1999).”
InfluentialResidual cognitive effects of long-term cannabis use
Pope, H. G., & Yurgelun-Todd, D. (2004) · Marijuana and Madness · doi:10.1017/cbo9780511543630.015 · Cited by 7
Toulami, M., Ghasemi, K., Rafei, P., Sangchooli, A., Nafissi, N., Zonoozi, A. K., Ardabili, H. M., Ebrahimi, M., Rezapour, T., & Ekhtiari, H. (2025) · Addiction · doi:10.1111/add.70064 · Cited by 9
“(Continues) The MCQ [32] was the most frequently used questionnaire (90.7%, n = 39), followed by the Marijuana Craving Checklist (MCC) [63] (9.3%, n = 4) (Table 6).”
InfluentialSinclair, J., Kalk, N. J., Kaar, S. J., Agabio, R., Arunogiri, S., Bisaga, A. M., Chesney, E., Daly, C., Dewhurst, J., Freeman, T. P., et al. (2026) · Journal of Psychopharmacology · doi:10.1177/02698811251399593 · Cited by 10
“In controlled abstinence studies, up to half of treatment-seeking cannabis users report severe withdrawal symptoms (Budney et al., 1999).”
Bond, B. W., Duric, B., Spinazzola, E., Trotta, G., Chesney, E., Li, Z., Quattrone, D., Tripoli, G., Gayer-Anderson, C. E., Rodríguez, V., et al. (2025) · The Canadian Journal of Psychiatry · doi:10.1177/07067437241290187 · Cited by 6
Alexander, D., & Leung, P. (2011) · Addictive Behaviors · doi:10.1016/j.addbeh.2011.06.008 · Cited by 6
Alexander, D. (2003) · Journal of Social Work Practice in the Addictions · doi:10.1300/j160v03n04_03 · Cited by 6
“…disorders, risky sexual behavior and aggressive behavior during withdrawal (Arseneault et al., 2002; Boyer et al., 1999; Brook et al., 2002; Budney et al., 1999; Fergusson, Horwood, & Swain-Campbell, 2002; Fried, 2002; Galif et al., 2001; Gfroerer, Wu, & Penne, 2002; Gorman & Derson,…”
BackgroundHuman Laboratory Models of Cannabis Use Disorder
Arout, C. A., Herrmann, E. S., & Haney, M. (2018) · Springer eBooks · doi:10.1007/978-3-319-90365-1_9 · Cited by 6
Crook, C. L., Savin, M. J., Byrd, D., Summers, A. C., Guzman, V. A., Morris, E. P., Tureson, K., Aghvinian, M. N., Cham, H., & Mindt, M. R. (2020) · AIDS Care · doi:10.1080/09540121.2020.1822504 · Cited by 6
Bahji, A., & Gorelick, D. A. (2022) · The Canadian Journal of Addiction · doi:10.1097/cxa.0000000000000155 · Cited by 6
Vorspan, F., Guillem, E., Bloch, V., Bellais, L., Sicot, R., Noble, F., Lépine, J., & Gorelick, D. A. (2011) · L Encéphale · doi:10.1016/j.encep.2010.12.007 · Cited by 5
Co-Occurring Addiction and Psychiatric Disorders
Greenfield, S. F., & Crisafulli, M. A. (2012) · Oxford University Press eBooks · doi:10.1093/med:psych/9780199738168.003.0007 · Cited by 5
Use of Guanfacine for Cannabis Use Disorder and Related Symptomology
Holst, M., Mathai, D. S., Patel, M. M., Rodgman, C., Keller, J., Hussain, M. Z., De La Garza, R., Kosten, T. R., & Verrico, C. D. (2019) · The American Journal on Addictions · doi:10.1111/ajad.12959 · Cited by 5
Can tobacco dependence provide insights into other drug addictions?
DiFranza, J. R. (2016) · BMC Psychiatry · doi:10.1186/s12888-016-1074-4 · Cited by 4
“The seminal research on tobacco withdrawal focused on individuals with advanced dependence [2–4], as was the case with research on withdrawal associated with other substances [5, 6].”
Shrier, L. A., McCaskill, N. H., Smith, M. C., O’Connell, M., Gluskin, B. S., Parker, S., Everett, V., Burke, P. J., & Harris, S. K. (2024) · Journal of Substance Use and Addiction Treatment · doi:10.1016/j.josat.2024.209472 · Cited by 4
Randomized controlled trial of zolpidem as a pharmacotherapy for cannabis use disorder
Lee, D. C., Schlienz, N. J., Herrmann, E. S., Martin, E. L., Leoutsakos, J., Budney, A. J., Smith, M. T., Tompkins, D. A., Hampson, A. J., & Vandrey, R. G. (2023) · Journal of Substance Use and Addiction Treatment · doi:10.1016/j.josat.2023.209180 · Cited by 4
Self-citationDing, J.-E., Yang, S., Zilverstand, A., Kulkarni, K. R., Gu, X., & Liu, F. (2024) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2024.3462371 · Cited by 5
“After the MRI scans, participants completed the marijuana craving questionnaire [37], marijuana withdrawal checklist, and marijuana problem investigation [38].”
Galang, J. N., Babson, K. A., Boden, M. T., & Bonn‐Miller, M. O. (2014) · Anxiety Stress & Coping · doi:10.1080/10615806.2014.934228 · Cited by 5
Freichel, R., Kroon, E., Kuhns, L., Filbey, F. M., Veer, I. M., Wiers, R. W. H. J., & Cousijn, J. (2023) · Cannabis and Cannabinoid Research · doi:10.1089/can.2022.0239 · Cited by 4
“37 As widely discussed in the network analysis literature, central symptoms may represent relevant targets with a prognostic utility for intervention efforts.”
Karila, L., Coscas, S., Lecacheux, M., Noble, F., Legleye, S., Beck, F., Dupont, P., Benyamina, A., Karmous, R., & Reynaud, M. (2008) · EMC - Traité de médecine AKOS · doi:10.1016/s1634-6939(08)48039-0 · Cited by 4
Síndrome de abstinencia y otros efectos en jóvenes fumadores de hachís
Rodrigo, M. D. B., Atance, J. A. R., García, M. L., et al. (2004) · Adicciones · doi:10.20882/adicciones.414 · Cited by 4
“Se utilizó una escala validada denominada WDS (Withdrawal discomfort score) que pertenece a los 10 síntomas de aparición más habitual del cuestionario MWC (Marihuana Withdrawal Checklist) ( Budney et al 1999).”
BackgroundMarijuana Arrests and Increase in Marijuana Use Disorders
Earleywine, M. (2004) · JAMA · doi:10.1001/jama.292.7.802-a · Cited by 4
Anxiety sensitivity and cannabis use: A systematic review and conceptualization of research findings
Short, N. A., Weese, R., Pezza, M., & Bedard‐Gilligan, M. A. (2025) · Behaviour Research and Therapy · doi:10.1016/j.brat.2025.104733 · Cited by 3
Lu, S., Cameron, K., Ganesan, S., Feldman, B., & McKenna, M. M. (2013) · Mental Health and Substance Use · doi:10.1080/17523281.2012.693520 · Cited by 3
Induction and comparison of craving for tobacco, marijuana and crack
Araújo, R. B., de Castro, M. D. G. T., Pedroso, R. S., Lucena‐Santos, P., Balbinot, A. D., Fischer, V. J., & Marques, A. C. P. R. (2015) · Archives of Clinical Psychiatry (São Paulo) · doi:10.1590/0101-60830000000061 · Cited by 3
Animal Models of Cannabis Use Disorder
Justinová, Z. (2018) · Springer eBooks · doi:10.1007/978-3-319-90365-1_8 · Cited by 3
A Review of the Effects of Adolescent Cannabis Use on Physical Health
Tuvel, A. L., Winiger, E. A., & Ross, J. M. (2023) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2023.03.005 · Cited by 4
“Stressing out”: defining severity of cannabis withdrawal symptoms in Australian indigenous inmates
Rogerson, B., & Jacups, S. P. (2015) · Journal of Substance Use · doi:10.3109/14659891.2015.1035347 · Cited by 3
“Scores were then re-collapsed to the four-point scale with 0 (not at all), 1–3 (mild), 4–6 (moderate), to 7–9 (severe) to enable comparisons with existing literature (Budney et al., 1999).”
BackgroundMethodResultInfluentialMarijuana and Cannabinoid Research
Emmanuel, O. S. (2005) · Humana Press eBooks · doi:10.1385/1592599990 · Cited by 3
Jager, G. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3375-0_11 · Cited by 3
Hämmig, R., Preuss, U. W., & Soyka, M. (2018) · Elsevier eBooks · doi:10.1016/b978-3-437-23021-9.00009-6 · Cited by 3
Psychotherapeutic interventions for cannabis abuse and/or dependence in outpatient settings
Denis, C., Lavie, E., Fatseas, M., & Auriacombe, M. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005336.pub3 · Cited by 3
RetractedCannabis Use Patterns and Blood Profiles in Adolescent Cannabinoid Hyperemesis Syndrome
Bloom, J., Beaudoin, F. L., Lin, T. R., Gaipo, A., Ortega, C., & Wightman, R. (2025) · Pediatric Emergency Care · doi:10.1097/pec.0000000000003495 · Cited by 2
Mehta, D. D., Goud, R., Sanches, M., Buckley, L. B., Sloan, M. E., Vandervoort, J., Foll, B. L., Beyraghi, N., Kaduri, P., Zawertailo, L. A., et al. (2026) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2026.113048 · Cited by 2
Zakala, C., Zhao, S., Battistuzzi, A., Nette, A., Matheson, J., Foll, B. L., Brands, B., Wickens, C. M., Kaduri, P., Hasan, O. S. M., et al. (2026) · Journal of Cannabis Research · doi:10.1186/s42238-026-00416-w · Cited by 2
PET imaging of FAAH in chronic Cannabis users: longitudinal assessment during short-term abstinence
Poluga, C., Dheda, S. S., Boachie, N., McCluskey, T., Narciso, L., Zilberman, M., Cote, C., Huestis, M. A., Tyndale, R. F., Kloiber, S. M., et al. (2026) · Neuropsychopharmacology · doi:10.1038/s41386-026-02438-7 · Cited by 2
Self-Initiated Cannabis Use Cessation in Adolescents and Emerging Adults
Tsai, J., Little, M. A., & Sussman, S. Y. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-800756-3.00125-3 · Cited by 2
Balodis, I. M., & MacKillop, J. M. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.80344 · Cited by 3
Elevating Endogenous Cannabinoids Reduces Opioid Withdrawal in Mice
Ramesh, D. (2012) · VCU Scholars Compass (Virginia Commonwealth University) · doi:10.25772/xdwb-4257 · Cited by 2
“Furthermore, only a subset of regular marijuana users experience a clustering of symptoms upon cessation of use, with reports of frequency ranging from 1/6 up to 1/2 (Wiesbeck et al., 1996; Budney et al., 1999).”
BackgroundDo I smell pot? A trial of an alternative paradigm of olfactory cue-reactance to marijuana
Loflin, M., & Earleywine, M. (2013) · Addiction Research & Theory · doi:10.3109/16066359.2013.805750 · Cited by 2
Clinical Implications of Epidemiologic Data for Diagnosis and Treatment of Psychiatric Comorbidity
Samet, S., & Hasin, D. S. (2008) · Psychiatric Annals · doi:10.3928/00485713-20081101-10 · Cited by 2
VALIDAÇÃO PSICOMÉTRICA DO MARIJUANA CRAVING QUESTIONNAIRE -SHORT FORM VERSÃO BRASIL
Pedroso, R. S., de Castro, M. D. G. T., Lucena‐Santos, P., Polese, G. P., Balbinot, A. D., Fischer, V. J., Oppermann, C. M. D. O., & Araújo, R. B. (2014) · Clinical & Biomedical Research · doi:10.4322/2357-9730.50919 · Cited by 2
Distress Intolerance and Cannabis Use: An Initial Empirical Investigation
Hogan, J. (2015) · ScholarWorks -A service of University of Vermont Libraries (University of Vermont) · Cited by 2
Can marijuana use lead to marijuana dependence?
Budney, A. J., & Wiley, J. L. (2001) · American Psychological Association eBooks · doi:10.1037/10441-008 · Cited by 2
Self-citationClinical Manifestations of Cannabis Use Disorder
Budney, A. J., Borodovsky, J. T., & Knapp, A. A. (2018) · Springer eBooks · doi:10.1007/978-3-319-90365-1_10 · Cited by 2
Self-citationSensory gating in tobacco-naïve cannabis users is unaffected by acute nicotine administration
Francis, A. M., Parks, A., Choueiry, J., El-Marj, N., Impey, D., Knott, V., & Fisher, D. J. (2021) · Psychopharmacology · doi:10.1007/s00213-021-05843-6 · Cited by 2
“TheMarijuanaWithdrawal Checklist (Budney et al. 1999) is a 22-item scale that measures symptoms of marijuana withdrawal after a period of abstinence.”
BackgroundMethodInfluentialSchlienz, N. J., & Vandrey, R. G. (2018) · Springer eBooks · doi:10.1007/978-3-319-90365-1_11 · Cited by 3
Silverman, M. J. (2022) · Journal of Substance Use · doi:10.1080/14659891.2022.2091048 · Cited by 2
“, 2016 ● Cannabis withdrawal symptoms (APA, 2010) Rogerson & Jacups, 2016 ● Marijuana Withdrawal Checklist (Budney et al., 1999) Sheridan et al.”
Cannabinoids - Recent Perspectives and Applications in Human Health
JAMES, S. P. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.100996 · Cited by 2
Claus, B. B., Scherbaum, N., Specka, M., Roser, P., & Bonnet, U. (2023) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2023.2229830 · Cited by 2
“…symptoms (craving for cannabis, irritability, nervousness/anxiety, restlessness/tension, depression, anger/aggression, sleeplessness, strange dreams, loss of appetite, headache) which are rated on a 4-point scale (0 = not at all, 1 = mild, 2 = moderate, 3 = heavy) (Budney, Novy, and Hughes 1999).”
Drogenabhängigkeit (ICD-10 F1)
Gouzoulis‐Mayfrank, E., & Scherbaum, N. (2009) · Elsevier eBooks · doi:10.1016/b978-3-437-24900-6.50007-1 · Cited by 2
Development of the Thai Cannabis Risky Use Screening Test
Kanchanabat, S., Arunpongpaisal, S., & Hurst, C. P. (2018) · Journal of Drug Issues · doi:10.1177/0022042618795635 · Cited by 1
Skumlien, M., Greenwood, L., Arun, A. H., Goodwin, I., Paloubis, A., Rana, T. T., Quinones‐Valera, M., McTavish, E., Abbott, G., Dunsford, S., et al. (2026) · Addiction · doi:10.1111/add.70492 · Cited by 1
Psychopharmacology of Violence
Kruesi, M. J. P. (2007) · Cambridge University Press eBooks · doi:10.1017/cbo9780511816840.033 · Cited by 1
Lee, D., Schroeder, J. R., Karschner, E. L., et al. (2013) · American Journal on Addictions · doi:10.1111/j.1521-0391.2013.12088.x · Cited by 1
Koob, G. F., & Moal, M. L. (2006) · Elsevier eBooks · doi:10.1016/b978-012419239-3/50044-8 · Cited by 1
Boden, M. T., Babson, K. A., Vujanovic, A. A., Short, N. A., & Bonn‐Miller, M. O. (2013) · American Journal on Addictions · doi:10.1111/j.1521-0391.2013.12018.x · Cited by 1
Garcy, D. P., & Boehm, S. L. (2023) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2023.107290 · Cited by 1
Johnstone, S., Sorkhou, M., Zhang, M., Dermody, S. S., Rabin, R. A., & George, T. P. (2024) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2023.2292010 · Cited by 1
“Furthermore, cannabis craving and withdrawal was assessed weekly with the Marijuana Craving Questionnaire (MCQ; 26), and the Marijuana Withdrawal Symptom Checklist (MWS; 35), respectively.”
MethodThe Relationship Between Brain Activity and Craving Among Individuals With Cannabis Use Disorder
Zafarghandi, M. B. S., Vahed, N., Arezoomandan, R., & Pirmoradi, M. (2023) · Iranian Journal of Psychiatry and Clinical Psychology · doi:10.32598/ijpcp.29.3.4661.1 · Cited by 1
Cannabinoids to Treat Cannabis Use Disorders
Brezing, C., & LEVIN, F. R. (2018) · Springer eBooks · doi:10.1007/978-3-319-90365-1_19 · Cited by 1
From Bud to Brain: A Psychiatrist's View of Marijuana
Cermak, T. L. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108653428 · Cited by 1
Monitoring the impact of Cannabis Use
Foll, B. L. (2021) · Trends in Psychiatry and Psychotherapy · doi:10.47626/2237-6089-2021-0462 · Cited by 1
Metadata
- Authors
- Budney, A. J., Novy, P. L., & Hughes, J. R.
- Affiliations
- University of Vermont (US)
- Venue
- Addiction
- Publisher
- Wiley
- Published
- 1999-09
- Volume
- 94
- Issue
- 9
- Pages
- 1311-1322
- ISSN
- 0965-2140 (ISSN-L)
- 1360-0443
- OpenAlex
- W2119758521
- Cited by
- 348
- References
- 0
- Citations by year
- 2026: 10 · 2025: 9 · 2024: 11 · 2023: 15 · 2022: 12 · 2021: 11 · 2020: 18 · 2019: 12 · 2018: 22 · 2017: 15 · 2016: 10 · 2015: 17 · 2014: 15 · 2013: 11 · 2012: 16
- FWCI
- 3.22
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Addiction (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r29da008655-05)
- National Institute on Drug Abuse (R-29DA08655)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Keywords
- cannabis use disorder, withdrawal symptom severity, psychiatric comorbidity, addiction treatment, cannabis
- MeSH terms
- Adult, Analysis of Variance, Marijuana Abuse, Female, Humans, Male, Patient Acceptance of Health Care, Regression Analysis, Stress, Psychological, Substance Withdrawal Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review